Target intelligence / Profile preview

Nijmegen breakage syndrome protein 1 (NBN)

Target
NBN
Molecular classification
DNA repair protein, Adapter protein, Component of MRN complex
01

Overview

Nijmegen breakage syndrome protein 1 (nibrin; NBN) is a key DNA repair protein encoded by the NBN gene, functioning as a core adapter in the MRN complex together with MRE11 and RAD50[1][3]. This complex is essential for recognizing and repairing DNA double-strand breaks, activating checkpoint signaling, maintaining chromosomal stability, and promoting homologous recombination and telomere integrity[1][3]. Nibrin mediates recruitment of repair proteins to DNA damage sites, and is required for critical processes like immunoglobulin class-switch recombination in B lymphocytes[2]. Mutations in NBN cause Nijmegen breakage syndrome, an autosomal recessive disorder distinguished by microcephaly, cancer predisposition, immunodeficiency, and sensitivity to ionizing radiation[3]. Nibrin is not an enzyme or receptor, but is considered a valid therapeutic target in cancer research and genetic diagnostics[3].

Other names
NibrinNBNNBSNBS1P95hNbs1ATVAT-V2AT-V1Cell cycle regulatory protein p95p95 protein of the MRE11/RAD50 complexNijmegen breakage syndrome 1 (nibrin)
02

Biological functions

DNA double-strand break repairDNA damage responseCell cycle controlRegulation of checkpoint activationHomologous recombinationTelomere maintenanceChromosomal stabilitySomatic recombination in B cells (immunoglobulin class-switch recombination)
03

Disease associations

Cancer (notably hematopoietic malignancy and B cell lymphoma)Immunodeficiency (Nijmegen breakage syndrome)Chromosomal instability disordersNeurodevelopmental disorders (microcephaly, growth retardation in NBS)
04

Safety considerations

Genetic deficiency increases mutation risk, cancer predisposition, and radiosensitivityOccasional defects in DNA repair may confer hypersensitivity to ionizing radiation and chemotherapies that induce DNA double-strand breaksImmunodeficiency and impaired class-switch recombination leading to variable antibody deficiency
05

Biomarkers

NBN mutation for diagnosis of Nijmegen breakage syndromeIncreased microhomology at recombination junctions in B cells (NBS patients)

Beyond the preview

Go deeper on Nijmegen breakage syndrome protein 1 (NBN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nijmegen breakage syndrome protein 1 (NBN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call